In this recent paper, authors present norm scores for the Amsterdam Instrumental Activities of Daily Living Questionnaire (A-IADL-Q) and provide an optimal cutoff for dementia.

Data from EPAD, EMIF-AD & Dutch Brain Research Registry were used.

bit.ly/3y4p4j9

In a study published in Cerebral Circulation - Cognition and Behavior, researchers from University of Glasgow assessed the clinical utility of the brain health index in the EPAD cohort.

Congratulations Jodi Watt🏳️‍🌈, David Dickie, Fred Ho, Donald Lyall, Jesse Dawson, Dr Terry Quinn💙👏

sciencedirect.com/science/articl…

It's #BrainAwarenessWeek 🧠 and we're shining the spotlight on a recent issue of Frontiers in Neurology which focused on the impact that IMI projects have had on #AlzheimersDisease 🙌📖 Read it@ europa.eu/!MbFHv6 #BrainResearch #IHITransformingHealth #HealthResearch

Another inspiring day at #ADPD2024 🇵🇹

👏 Kudos to Leonard Pieperhoff for his excellent presentation on the association between cortical amyloid deposition and subsequent neurodegeneration in participants from the AMYPAD Prognostic Study

How can we make more data accessible to everyone? Jean Manson shares how @imi_epad pioneered the collection and sharing of #Alzheimers samples at scale––with over 100,000 samples available on the #ADWorkbench thanks to broad participant involvement across the EU.

Thanks again to everyone who came out to our #datasharing symposium yesterday at #ADPD2024 ! Our chair Phyllis Ferrell moderated a great conversation––some highlights from our partners 👇

Announcing the enhanced @IMI_EPND Catalogue!

It offers new pathways for collaborative research and sharing of biosamples and data. Explore how the improved visibility and discoverability of studies can further support your research ➡️

bit.ly/EPNDCatalogue
(1/2)

Great to hear Alzheimer's Disease Data Initiative partners sharing the latest insights on their research & key efforts to make data and samples accessible at #ADPD2024 .
Phyllis Ferrell European Platform for Neurodegenerative Diseases EPAD

Happening now at #ADPD2024 Booth 42:
🔷 Dr. Ioannis Pappas providing demos for GAAIN Alzheimer's Association
🔷 Special booth guests from EPAD EU-FINGERS and Davos Alzheimer’s Collaborative

Stop by during today's sessions to learn from our global data and platform partners

Good morning #ADPD2024 ✨

👉Drop by Alzheimer's Disease Data Initiative Booth 42 to meet the EPAD guests Jean Manson & Josie Butchart

🔔Join the ADDI Symposium at 18:40 to hear more about accessibility of data and samples to the broader research community EPAD Davos Alzheimer’s Collaborative European Platform for Neurodegenerative Diseases Phyllis Ferrell

#ADPD2024 Day 2 is a wrap! It’s been a great day at booth 42:

✔️Platform Demos from DPUK GAAIN and @IMI_EPND
✔️ #IMI_EPND co-leads Tony Brookes and @NiranjanBose, with Angela Bradshaw
✔️Data contributing partners EPAD

Join us at #ADPD2024 tomorrow! Prof. Jean Manson will speak about the valuable EPAD data and samples in a symposium supported by Alzheimer's Disease Data Initiative ⬇️

Welcome to #ADPD2024 !
The conference has officially kicked off, and we're thrilled to be here in #Lisbon with our global community of experts in #neurodegenerative diseases. 🧠
Stay tuned for more updates and insights as we delve into the latest advancements in the field. 🌟

We are at #ADPD2024 ! Meet us at the Alzheimer's Disease Data Initiative booth 42 today to discuss about our EPAD data and samples and how you can access to them.

✨See you there!

Join us at #ADPD2024 next week! Prof. Jean Manson will speak about the valuable EPAD data & samples in a symposium supported by Alz Dat titled 'How several key efforts are making their data and samples accessible to the broader research community'
#datasharing #collaboration

We’ll be at #ADPD2024 ! We look forward to joining our partners in demonstrating how AD Data Initiative resources can help researchers like you accelerate findings.

Congratulations to Eddy Roccati for his paper investigating how modifiable risk factors relate to the three hallmark AT(N) biomarkers of Alzheimer's disease with the findings from the EPAD study ⬇️

James Vickers Aidan βindoff-42 (not my real age) A/Prof Jane Alty

frontiersin.org/articles/10.33…

Our paper on modifiable risk factors and AT(N) criteria is out now in Frontiers. 🙌 Thank you to Alzheimer's Disease Data Initiative for supporting this work, and providing the #NeuroToolKit on the AD Workbench that enabled this investigation 🧠
tinyurl.com/24tzlmnr

Machine learning offers an advantage over logistic regression when predicting Alzheimer’s and non-Alzheimer’s pathology as defined through the ATN classification in pre-dementia individuals EPAD PLOS ONE

Congratulations Ivan Koychev & colleagues👏

doi.org/10.1371/journa…

New EPAD publication out from @BarcelonaBetaresearchers investigating the association between subjective sleep measures and CSF biomarkers of #Alzheimer 's disease. Congratulations Laura Stankeviciute, PhD and all authors!
alzheimer-europe.org/news/new-epad-…